Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News Out On Tuesday

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Aug 03, 2024 5:49pm

176 Views

Post# 36163519

RE:RE:RE:News Out On Tuesday

I agree....The 2022 market meltdown & the one brewing currently act like anchors on the sp, but on the flip side, they offer impact-minded investors great buying opportunities, especially in this type of specialized market where gold is buried in anonymity.

It's rare to see any pre-revenue "smaller" biotech continue to amble forward with such low R&D costs despite the exposure to recessionary pressures & the general market anonymity. One investor's risk/trash is another's treasure/opportunity. Fortunately for us, our treasure has been hidden. Should have another nice buy signal coming next week....all imo.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023